Contact information
Colleges
Oliver Rider
BA (hons), BMBCh (hons), FRCP (UK), DPhil (Oxon)
Professor of Cardiovascular Medicine
- British Heart Foundation Senior Clinical Research Fellow
- Deputy Clinical Director of OCMR
- Honorary Consultant Cardiologist
After studying medicine at Pembroke College (1996-2002) I completed the Royal College Examinations and specialized in Cardiology. In 2005 I was awarded a Wellcome Trust Junior Research Fellowship to complete my DPhil in Cardiovascular medicine at Oxford, where I used advanced cardiac magnetic resonance imaging and spectroscopy to study the effects of obesity and weight loss on myocardial metabolism and function. For this work I was awarded the American Heart Association Young Investigator Award for Nutrition Physical Activity and Metabolism (2008) and took up the role of Clinical Lecturer in Cardiovascular Medicine in Oxford in 2010 where I furthered my research into obesity. In 2015 I was appointed as an Honorary Consultant Cardiologist and Deputy Clinical Director or the University of Oxford Centre for Clinical Magnetic Resonance Research. I held a British Heart Foundation Intermediate Clinical Research Fellowship between 2016 and 2022 and was awarded the BHF/BCS Michael Davies Early Career Award in 2019, and followed this with a British Heart Foundation Senior Clinical Research Fellowship award in 2022. I now run a research group that uses advanced cardiac magnetic resonance imaging and spectroscopy to investigate the relationship between cardiac substrate metabolism, cardiac energetics and cardiac function in multiple diseases with a focus on cardiometabolic heart disease and heart failure.
Recent publications
Faster and More Robust CK Reaction Rate Estimation at 3T Using Acquisition-Weighted 31P Cardiac 1D-MRSI With Compartment-Based Reconstruction.
Journal article
Axford A. et al, (2026), Magn Reson Med
Severe Aortic Stenosis Is Associated With Left Atrial Prothrombotic Flow That Persists Despite Valve Replacement.
Journal article
Spartera M. et al, (2026), J Am Heart Assoc
Clinical Applications of Artificial Intelligence in Cardiovascular Imaging: Where Do We Stand?
Journal article
Singhal AA. et al, (2026), Life (Basel), 16
Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia.
Journal article
Bussmann BM. et al, (2026), BMJ Open, 16
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.
Journal article
Hundertmark MJ. et al, (2026), Circulation, 153, 550 - 563
